Medical Services International Marketing Program Shows Results

EDMONTON, Alberta, March 29  /PRNewswire-FirstCall/ -- Medical Services International Inc (OTC:MSITF) is pleased to announce that its marketing program for the VScan rapid test kits is showing excellent results. In the last several months the company has received requests from 37 companies to become distributors of the VScan products. By fall 2007 the Company expects to sign up a total of 100 new distributors. This will generate $250,000 US in distribution fees and a minimum of 500,000 VScan kits orders.  The Company is receiving additional inquiries and requests from companies and individuals to become distributors each week. To become a distributor of VScan products, a deposit of $2500 US is required. Initial orders range from 5000 to 10,000 kits depending on the location. The interest in being a distributor of the VScan test kits can be attributed directly to the test results that are being obtained throughout the world by regulatory agencies. In addition to kits for the detection of HIV 1&2, the Company is getting inquiries about the fact that the VScan HIV test kit detects Subgroup O. This is a new form of HIV that is prevalent in Africa and is moving to North America. The VScan HIV test kit is the only rapid test kit available that can test for Subgroup O.

About VScan

The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.

Medical Services International Inc trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at [phone] or http://www.medicalservicesintl/ or http://www.minerva-biotech.com/ .

NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies. 

DATASOURCE: Medical Services International Inc



CONTACT: Robert Talbot of Medical Services International,

[phone]



Web site:  http://www.medicalservicesintl.com/

http://www.minerva-biotech.com/ 

Copyright